ATE272389T1 - Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten - Google Patents

Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten

Info

Publication number
ATE272389T1
ATE272389T1 AT01931980T AT01931980T ATE272389T1 AT E272389 T1 ATE272389 T1 AT E272389T1 AT 01931980 T AT01931980 T AT 01931980T AT 01931980 T AT01931980 T AT 01931980T AT E272389 T1 ATE272389 T1 AT E272389T1
Authority
AT
Austria
Prior art keywords
lacrophyl
active substance
therapeutically effective
eye drops
drops containing
Prior art date
Application number
AT01931980T
Other languages
English (en)
Inventor
Kahan Ilona Molnarne
Original Assignee
Kahan Ilona Molnarne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kahan Ilona Molnarne filed Critical Kahan Ilona Molnarne
Application granted granted Critical
Publication of ATE272389T1 publication Critical patent/ATE272389T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01931980T 2000-05-04 2001-05-04 Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten ATE272389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001769A HUP0001769A2 (hu) 2000-05-04 2000-05-04 Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben
PCT/HU2001/000053 WO2001082893A1 (en) 2000-05-04 2001-05-04 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds

Publications (1)

Publication Number Publication Date
ATE272389T1 true ATE272389T1 (de) 2004-08-15

Family

ID=89978306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931980T ATE272389T1 (de) 2000-05-04 2001-05-04 Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten

Country Status (9)

Country Link
US (1) US6949241B2 (de)
EP (1) EP1278511B1 (de)
AT (1) ATE272389T1 (de)
AU (1) AU2001258662A1 (de)
CA (1) CA2407794A1 (de)
DE (1) DE60104670T2 (de)
ES (1) ES2248326T3 (de)
HU (1) HUP0001769A2 (de)
WO (1) WO2001082893A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229814A1 (en) * 2002-08-28 2004-11-18 James Dillon Methods and compositions for protecting against cataract development associated with vitrectomies
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
US20070259021A1 (en) * 2006-05-01 2007-11-08 Friedlaender Mitchell H Compositions, Methods, and Kits for Treating Dry Eye
CA2679937A1 (en) * 2007-03-02 2008-09-12 Stefano Ferrari Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
CN103182075B (zh) * 2011-12-30 2015-07-22 沈阳兴齐眼药股份有限公司 一种溶菌酶制剂、其制备方法及用途
WO2016014437A1 (en) * 2014-07-21 2016-01-28 Hiroaki Serizawa Ophthalmic compositions of rifamycins and uses thereof
WO2016077457A1 (en) 2014-11-11 2016-05-19 Clara Foods Co. Methods and compositions for egg white protein production
WO2017209721A1 (en) 2016-06-02 2017-12-07 Alemdar Eda A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
FI13395Y1 (fi) 2019-07-11 2023-06-06 Clara Foods Co Koostumuksia, jotka käsittävät rekombinanttia ovomukoidiproteiinia
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
US20240058329A1 (en) * 2020-12-21 2024-02-22 Bnc Korea Co., Ltd. Ophthalmic composition of rifamycin, and use thereof
US12005093B2 (en) * 2022-08-11 2024-06-11 Hong Kong Chinese Medicine Ophthalmology Institute Limited Traditional chinese medicine eye drops and the preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
HU209538B (en) * 1990-05-09 1994-07-28 Vepex Contractor Ltd Set and cleaning composition for treating contactlenses

Also Published As

Publication number Publication date
HU0001769D0 (en) 2000-07-28
HUP0001769A2 (hu) 2002-01-28
US20030124112A1 (en) 2003-07-03
AU2001258662A1 (en) 2001-11-12
US6949241B2 (en) 2005-09-27
EP1278511A1 (de) 2003-01-29
DE60104670D1 (de) 2004-09-09
ES2248326T3 (es) 2006-03-16
WO2001082893A1 (en) 2001-11-08
EP1278511B1 (de) 2004-08-04
DE60104670T2 (de) 2005-01-13
CA2407794A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
DE60104670D1 (de) Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten
CL2010000606A1 (es) Uso de derivados de eritropoyetina en la preparacion de un medicamento util para proteger, mantener, mejorar o recuperar la viabilidad de celulas que responden a eritropoyetina en condiciones anomalas que afectan las celulas, tejidos u organos asociados; derivados de eritropoyetinas y composicion que las comprende (divisional de la solicitud 3188-2001).
ATE210943T1 (de) Ophthalmologisches abgabesystem
DE69617723D1 (de) Wachsumsfaktoren enthaltende gelformulierungen
AU2525401A (en) Use of an extract of at least one vaccinium-type plant as an anti-glycation agent
CA2182576A1 (en) Bilayer preparations
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
ATE321533T1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
MY114300A (en) Pesticidal mixtures comprising diafenthiuron and a carbamate
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
WO2002049615A3 (en) Artificial tear composition containing a combination of three demulcents
KR970702734A (ko) 안과용 조성물에서 아미도아민의 용도(use of amidoamines in ophthalmic compositions)
AU2001278708A1 (en) Adenosine derivatives and use thereof
DK0413793T3 (da) Koncentrerede vandige emulsioner, en fremgangsmåde til deres fremstilling og deres anvendelse på pesticidområdet
EA199800435A1 (ru) Пестицидный препарат
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
TR200201148T2 (tr) Haşerat ilacı terkipleri ve metodları.
MD1762B2 (ro) Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile
TR199701617T1 (xx) �iftliklerde �retilen bal�klarda g�r�len parazitlerle m�cadelede kullan�lacak bir ajan.
SE9302203D0 (sv) Composition for ophthalmic use
EP0175490A3 (de) Zusammensetzungen zur Behandlung von Kontaktlinsen und ihre Anwendung
RU94032143A (ru) Композиция, содержащая препарат коагуляционного фактора viii, способ ее получения и применение поверхностно-активного вещества в качестве стабилизатора
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties